For the second year running,…
For the second year running, Pfizer has arrived at the [...]
For the second year running, Pfizer has arrived at the [...]
Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, [...]
Danish vaccine developer Evaxion has released long-term data for its [...]
Roche’s giredestrant was shown to reduce the risk of breast [...]
For the second time, Astellas is walking away from Taysha [...]
The president unveiled several policy proposals on Thursday aimed at [...]
In the first opportunity for industry watchers to compare the [...]
Gilead’s Kite Pharma is doubling down on in vivo CAR-T, [...]
Results presented by AstraZeneca from its phase 3 trial of [...]
Dianthus and Boehringer Ingelheim headlined the latest round of licensing [...]